XLV vs ARKK — 11-Year Performance Comparison
Health Care vs ARK Innovation — backtested 2014–2024
ARKK wins$30,519 vs $30,023 on $10,000 over 11 years
XLVHealth Care
Final value$30,023
CAGR+10.5%
Max drawdown-2.7%
Best year+26% (2021)
Years won5 of 11
ARKKARK Innovation
Final value$30,519
CAGR+10.7%
Max drawdown-74.7%
Best year+152% (2020)
Years won6 of 11
Growth of $10,000
2014–2024XLVARKK
XLV$30,023
ARKK$30,519
50/50 mix$41,330
50/50 blend: $41,330 (+13.8%/yr CAGR)
Splitting equally between XLV and ARKK would have outperformed both individually — diversification smoothed the ride. Try a custom split →
Year-by-year: XLV vs ARKK
| Year | XLV | ARKK | Winner |
|---|---|---|---|
| 2024 | +2.6% | +8.4% | ARKK |
| 2023 | +2.1% | +67.6% | ARKK |
| 2022 | -2.1% | -67.0% | XLV |
| 2021 | +26.1% | -23.4% | XLV |
| 2020 | +13.4% | +151.9% | ARKK |
| 2019 | +20.8% | +35.1% | ARKK |
| 2018 | +6.5% | +3.5% | XLV |
| 2017 | +22.1% | +87.3% | ARKK |
| 2016 | -2.7% | -2.0% | ARKK |
| 2015 | +6.9% | +3.8% | XLV |
| 2014 | +25.3% | -1.1% | XLV |
More comparisons
Build your portfolio
Mix XLV + ARKK with custom allocations
Try a 70/30 or 40/60 split — or add up to 3 more ETFs. See exactly how your custom portfolio would have performed.
Open Portfolio Builder →Past performance does not guarantee future results.